Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures. The ...

Abbott Laboratories (ABT) said on Monday it agreed to pay $1.6 billion to resolve civil and criminal allegations related to the promotion of anti-seizure drug Depakote for unapproved uses. The ...

Divalproex sodium 250mg, 500mg; ext-rel tabs. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have ...

Divalproex sodium 125mg; coated particles in caps. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects ...

WASHINGTON (AP) -- Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food ...

Settles civil, criminal charges from US, 49 states Abbott to plead guilty to one misdemeanor Charges involve promoting Depakote for unapproved uses Enters Corporate Integrity agreement for 5 years ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures. The ...